Studies in individuals with NAFLD and non-alcoholic steatohepatitis (NASH) illustrate that fat accumulation in the liver reduces the sensitivity of hepatocytes towards glucagon [16, 17]. Here, GCG is linked to metabolic dysfunction-associated steatotic liver disease.